19 June 2013
Keywords: eisai, withdraws, cefclidin, application, withdrawn, its, japanese
Article | 23 January 1995
Eisai has withdrawn its Japanese approval application for the antibiotic
cefclidin due to a high incidence of rash caused by ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
23 January 1995
18 June 2013
© 2013 thepharmaletter.com